HHS

In an exclusive interview with Benzinga, Carlos Pinto, chief commercial officer (CCO) of Leafly Holdings Inc. (NASDAQ: LFLY) discussed the strategic shift the cannabis marketplace and education platform has undergone. He also shared his perspective on the Department of Health...

Could the future of healthcare be intertwined with cannabis-based medicines? A recent report by Prohibition Partners, a data, media and tech company operating in the cannabis industry, reveals a remarkable 650% surge in clinical trials using cannabis-based medicines to alleviate symptoms...

Leafly Holdings, Inc. (NASDAQ: LFLY) annual Cannabis Harvest Report reveals that in some states, cannabis is consistently one of the highest-value crops in the field, though the federal government and some state and local governments do not track weed harvest...

In his weekly Dear Colleague letter, Senate Majority Leader Chuck Schumer (D-NY) renewed his call to pass a cannabis banking bill before the legislative period runs out. "In the remaining months of this year, we also have an opportunity to advance legislation on a number of...

The AdvisorShares Pure US Cannabis ETF (NASDAQ: MSOS) surged by more than 14% on Thursday as the whole cannabis sector experienced a boost of enthusiasm on news that the Department of Health and Human Services was officially directing the DEA to ease the onerous...

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...

Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS ETF (ARCA: MSOS) surged...

New York Senator Chuck Schumer (D) responded to Wednesday's news that the Dept. of  Health and Human Services wrote to DEA administrator Anne Milgram calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act.  Cannabis'...

The Department of Health and Human Services is recommending to the Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under federal law, according to a report by Bloomberg on Wednesday. Currently, cannabis is a Schedule I drug,...

A top official at the Department of Health and Human Services wrote to Drug Enforcement Agency administrator Anne Milgram calling for marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act, according to a letter dated Aug. 29 seen by Bloomberg...